{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:58:28Z","timestamp":1782403108531,"version":"3.54.5"},"reference-count":56,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Data on the interplay between muscle, bone, and adipose tissue metabolism in normal-weight children with Prader\u2013Willi syndrome (PWS) undergoing growth hormone (GH) therapy and dietary interventions are limited. This study aimed to assess the myokine profile and explore the associations between myokines, bone markers, adipokines, and body composition in these patients. The study included 26 children with PWS and 26 age-matched healthy controls. Serum levels of irisin, myostatin (MSTN), fibroblast growth factor-2, insulin-like growth factor-I (IGF-I), IGF-binding protein-2, bone alkaline phosphatase (BALP), osteocalcin (OC), carboxylated OC (Gla-OC), periostin, soluble receptor activator of nuclear factor kappa-B ligand, tartrate-resistant acid phosphatase 5b, leptin\/soluble leptin receptor, adiponectin, and proinsulin were measured using immunoenzymatic assays. Children with PWS had significantly lower lean mass (p = 0.047) and a higher fat mass\/lean mass ratio (p &lt; 0.001) than controls. Irisin levels were lower in the PWS group (p = 0.031), while MSTN levels were similar between the groups. In patients, irisin positively correlated with BALP (p = 0.025) and negatively correlated with Gla-OC (p = 0.041) and periostin (p = 0.005). MSTN was positively associated with proinsulin (p = 0.001) and negatively associated with lean mass (p = 0.015). OC concentration was lower in the PWS group and correlated positively with lean mass (p = 0.052). Children with PWS exhibit altered myokine, osteokine, and adipokine profiles, as well as differences in body composition. Reduced irisin and osteocalcin levels, along with the negative association between MSTN and lean mass, may impair muscle development and bone metabolism. These imbalances could also contribute to future metabolic disorders in patients with PWS.<\/jats:p>","DOI":"10.3390\/ijms262210822","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:56:45Z","timestamp":1762513005000},"page":"10822","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Myokine Levels in Relation to Bone Markers and Adipokines in Children with Prader\u2013Willi Syndrome During Growth Hormone Therapy and Dietary Intervention"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1349-0155","authenticated-orcid":false,"given":"Joanna","family":"Gajewska","sequence":"first","affiliation":[{"name":"Department of Screening Tests and Metabolic Diagnostics, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-6813","authenticated-orcid":false,"given":"Magdalena","family":"Che\u0142chowska","sequence":"additional","affiliation":[{"name":"Department of Screening Tests and Metabolic Diagnostics, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Szamotulska","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5538-0459","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Struci\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-0117","authenticated-orcid":false,"given":"Witold","family":"Klemarczyk","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-7561","authenticated-orcid":false,"given":"Jadwiga","family":"Ambroszkiewicz","sequence":"additional","affiliation":[{"name":"Department of Screening Tests and Metabolic Diagnostics, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome-clinical genetics, diagnosis and teatment approaches: An update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/clinem\/dgac556","article-title":"Bone health in adults with Prader-Willi syndrome: Clinical recommendations based on a multicenter cohort study","volume":"108","author":"Pellikaan","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neubiorev.2010.10.015","article-title":"Motor problems in Prader-Willi syndrome: A systematic review on body composition and neuromuscular functioning","volume":"35","author":"Reus","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.21037\/tp.2017.09.04","article-title":"Review of Prader-Willi syndrome: The endocrine approach","volume":"6","author":"Heksch","year":"2017","journal-title":"Transl. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11914-020-00600-8","article-title":"Myokines and osteokines in the pathogenesis of muscle and bone diseases","volume":"18","author":"Colaianni","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","article-title":"Muscle, bone, and fat crosstalk: The biological role of myokines, osteokines, and adipokines","volume":"18","author":"Kirk","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcdb.2021.10.009","article-title":"Muscle-derived factors influencing bone metabolism","volume":"123","author":"Gries","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16056","DOI":"10.1038\/boneres.2016.56","article-title":"Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism","volume":"5","author":"Zhang","year":"2017","journal-title":"J. Bone Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ijo.2014.42","article-title":"Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans","volume":"38","author":"Huh","year":"2014","journal-title":"Int. J. Obes."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e60563","DOI":"10.1371\/journal.pone.0060563","article-title":"FNDC5\/irisin is not only a myokine but also an adipokine","volume":"8","author":"Castelao","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e148372","DOI":"10.1172\/JCI148372","article-title":"Targeting the myostatin signalling pathway to treat muscle loss and metabolic dysfunction","volume":"131","author":"Lee","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1074\/jbc.M116.770941","article-title":"Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication","volume":"292","author":"Qin","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/a-0641-5546","article-title":"Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans","volume":"127","author":"Amor","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cyto.2017.12.008","article-title":"Myostatin and adipokines: The role of the metabolically unhealthy obese phenotype in muscle function and aerobic capacity in young adults","volume":"107","author":"Carvalho","year":"2018","journal-title":"Cytokine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/js.2018-00105","article-title":"Fibroblast growth factor 2 and its receptors in bone biology and disease","volume":"2","author":"Coffin","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e22547","DOI":"10.1016\/j.heliyon.2023.e22547","article-title":"Advances in the research on myokine-driven regulation of bone metabolism","volume":"10","author":"Shao","year":"2023","journal-title":"Heliyon"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/jbmr.1666","article-title":"Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men","volume":"27","author":"Lebrasseur","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"120067","DOI":"10.1016\/j.cca.2024.120067","article-title":"Osteocalcin: A bone protein with multiple endocrine functions","volume":"567","author":"Determe","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1287972","DOI":"10.3389\/fendo.2023.1287972","article-title":"Mechanism and physical activities in bone-skeletal muscle crosstalk","volume":"14","author":"Zhao","year":"2024","journal-title":"Front. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e4097","DOI":"10.7717\/peerj.4097","article-title":"Motor performance in Prader-Willi syndrome patients and its potential influence on caregiver\u2019s quality of life","volume":"5","author":"Chiu","year":"2017","journal-title":"PeerJ"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Casamitjana, L., Blanco-Hinojo, L., Gim\u00e9nez-Palop, O., Pujol, J., Mart\u00ednez-Vilavella, G., Esteba-Castillo, S., Pareja, R., Freijo, V., Vigil, L., and Deus, J. (2022). One year of recombinant human growth hormone treatment in adults with Prader-Willi syndrome improves body composition, motor skills and brain functional activity in the cerebellum. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071831"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41598-020-57855-5","article-title":"Irisin levels in genetic and essential obesity: Clues for a potential dual role","volume":"10","author":"Mai","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s40618-021-01533-4","article-title":"The genetic background and vitamin D supplementation can affect irisin levels in Prader-Willi syndrome","volume":"44","author":"Faienza","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gajewska, J., Szamotulska, K., Klemarczyk, W., Che\u0142chowska, M., Struci\u0144ska, M., and Ambroszkiewicz, J. (2023). Circulating levels of nesfatin-1 and spexin in children with Prader-Willi Syndrome during growth hormone treatment and dietary intervention. Nutrients, 15.","DOI":"10.3390\/nu15051240"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gajewska, J., Che\u0142chowska, M., Szamotulska, K., Klemarczyk, W., Struci\u0144ska, M., and Ambroszkiewicz, J. (2024). Differences in bone metabolism between children with Prader-Willi syndrome during growth hormone treatment and healthy subjects: A pilot study. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179159"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41467-017-01131-0","article-title":"Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy","volume":"8","author":"Reza","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"918467","DOI":"10.3389\/fendo.2022.918467","article-title":"Circulating irisin in children and adolescents with Prader-Willi syndrome: Relation with glucose metabolism","volume":"13","author":"Mai","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e0136864","DOI":"10.1371\/journal.pone.0136864","article-title":"Irisin and the metabolic phenotype of adults with Prader-Willi syndrome","volume":"10","author":"Hirsch","year":"2015","journal-title":"PLoS ONE"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yapd.2016.04.005","article-title":"Prader Willi syndrome: Genetics, metabolomics, hormonal function, and new approaches to therapy","volume":"63","author":"Irizarry","year":"2016","journal-title":"Adv. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1210\/me.2013-1194","article-title":"Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo","volume":"27","author":"Goodman","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0883073807299966","article-title":"Muscle myostatin expression in children with muscle diseases","volume":"22","author":"Carneiro","year":"2007","journal-title":"J. Child Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-015-0047-5","article-title":"Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: Insights using a new mass spectrometry-based assay","volume":"5","author":"Bergen","year":"2015","journal-title":"Skelet. Muscle"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diabres.2018.05.041","article-title":"Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients","volume":"142","author":"Tanaka","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101367","DOI":"10.1016\/j.mam.2025.101367","article-title":"The bone-muscle unit: From mechanical coupling to soluble factors-mediated signaling","volume":"103","author":"Malvandi","year":"2025","journal-title":"Mol. Aspects Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/ijmm.2023.5330","article-title":"Roles of vitamin K-dependent protein in biomineralization (Review)","volume":"53","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI133572","article-title":"Muscle-derived interleukin 6 increases exercise capacity by signaling in osteoblasts","volume":"130","author":"Chowdhury","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"18732","DOI":"10.1038\/srep18732","article-title":"Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways","volume":"6","author":"Qiao","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zerlotin, R., Oranger, A., Pignataro, P., Dicarlo, M., Maselli, F., Mori, G., Colucci, S.C., Grano, M., and Colaianni, G. (2022). Irisin and secondary osteoporosis in humans. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020690"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"867921","DOI":"10.3389\/fphys.2022.867921","article-title":"Musculoskeletal effects of altered GH action","volume":"13","author":"Young","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"124125","DOI":"10.1016\/j.ijbiomac.2023.124125","article-title":"The role of insulin-like growth factor-1 in bone remodeling: A review","volume":"238","author":"Fang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-0004.2004.00392.x","article-title":"Insulin resistance and obesity-related factors in Prader-Willi syndrome: Comparison with obese subjects","volume":"67","author":"Talebizadeh","year":"2005","journal-title":"Clin. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12766","article-title":"Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: Sex differences and the role of growth hormone","volume":"83","author":"Irizarry","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1515\/jpem-2017-0539","article-title":"The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome","volume":"31","author":"McAlister","year":"2018","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/jc.2014-3127","article-title":"Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: A model of extreme adiposity","volume":"100","author":"Lacroix","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.ijo.0803115","article-title":"Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: Comparison with obese subjects","volume":"30","author":"Kennedy","year":"2006","journal-title":"Int. J. Obes."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/apha.12686","article-title":"Crosstalk between adipokines and myokines in fat browning","volume":"219","author":"Becerril","year":"2017","journal-title":"Acta Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/07435800.2016.1198802","article-title":"Myostatin and carbohydrate disturbances","volume":"42","author":"Assyov","year":"2017","journal-title":"Endocr. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"28629","DOI":"10.1038\/s41598-024-79534-5","article-title":"Myostatin as a plausible biomarker for early stage of sarcopenic obesity","volume":"14","author":"Ishibashi","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Karampatsou, S.I., Genitsaridi, S.M., Michos, A., Kourkouni, E., Kourlaba, G., Kassari, P., Manios, Y., and Charmandari, E. (2021). The effect of a life-style intervention program of diet and exercise on irisin and FGF-21 concentrations in children and adolescents with overweight and obesity. Nutrients, 13.","DOI":"10.3390\/nu13041274"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2016.12.018","article-title":"Adiponectin profile and Irisin expression in Italian obese children: Association with insulin-resistance","volume":"94","author":"Nigro","year":"2017","journal-title":"Cytokine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12020-017-1476-1","article-title":"Irisin in metabolic diseases","volume":"59","author":"Polyzos","year":"2018","journal-title":"Endocrine"},{"key":"ref_53","unstructured":"Wajszczyk, B., Chwojnowska, Z., Nasiadko, D., and Rybaczuk, M. (2015). Dieta 5.0 Software for Individual and Group Nutrition Assessment and Diet Planning, National Food and Nutrition Institute."},{"key":"ref_54","first-page":"119","article-title":"Percentile charts for growth and nutritional status assessment in Polish children and adolescents from birth to 18 year of age","volume":"12","author":"Grajda","year":"2015","journal-title":"Stand. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.peptides.2014.03.015","article-title":"The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children","volume":"56","author":"Catli","year":"2014","journal-title":"Peptides"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Pratapwar, M.P., Sheth, H.J., Ravi, A.K., Block, M.L., Korber, K.A., Kepsel, A., Leimanis-Laurens, M., and Comstock, S.S. (2024). Use of biomarkers in nutrition intervention studies of children: A scoping review. Nutrients, 16.","DOI":"10.3390\/nu16213584"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/10822\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:58:55Z","timestamp":1762513135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/10822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":56,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262210822"],"URL":"https:\/\/doi.org\/10.3390\/ijms262210822","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]}}}